AlphaYouNG
Insider selling
Noah Goodman sold $387K of Kymera Therapeutics, Inc. (KYMR) stock
Noah Goodman, Chief Business Officer of Kymera Therapeutics, Inc. (KYMR), sold 3,389 shares of KYMR stock worth $387K, per an SEC Form 4 filed Jul 2, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 1, 2026, 1 day before it was made public.
KYMR has moved -3.2% since the trade date, from $114.20 to $110.51 (Sep 29, 2026 close).
- Traded
- Jul 1, 2026
- Disclosed
- Jul 2, 2026
- Filing delay
- 1 day
- Price since
- -3.2%
- Role
- Chief Business Officer
- Source
- SEC Form 4
More KYMR insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.